1-6 of 6
Lydia Sarah Hui Lee
Close
Sort by
Journal Articles

Development of a Phase 1 Study Evaluating the Activity of Modular CAR T for Multiple Myeloma (MCARTY) Targeting BCMA and CD19 for Improved Persistence

Lydia Sarah Hui Lee, Wen Chean Lim, Catriona Mactier, Juliana Dias Alves Pinto, Vitoria Pereira, Mhairi Vaughan, Louisa Green, Evie Lewin, John Garcia, Giulia Agliardi, Yashma Pathak, Riaz Jannoo, Leigh Wood, Bilyana Popova, Helen Holmes, Simon Thomas, Victoria Spanswick, William Wilson, Christopher Parrish, Rakesh Popat, Claire Roddie, Kwee Yong, Martin A. Pule
Journal: Blood
Blood (2023) 142 (Supplement 1): 350.
https://doi.org/10.1182/blood-2023-185085
Published: 2023
Journal Articles

The Impact of Continuous Lenalidomide Maintenance Treatment on People Living with Multiple Myeloma - a Single-Centre Qualitative Service Evaluation

Caroline Buck, Francisco Castillo, Elena Bettio, Kwee Yong, Annabel Mcmillan, Lydia Sarah Hui Lee, Xenofon Papanikolaou, Ke Xu, Charalampia Kyriakou, Neil Rabin, Ashutosh D. Wechalekar, Rakesh Popat, Joanne Land, Orla McCourt, Helen Poole, Rachel Tarling, Abigail Fisher, Jonathan Sive
Journal: Blood
Blood (2023) 142 (Supplement 1): 6640.
https://doi.org/10.1182/blood-2023-184914
Published: 2023
Journal Articles

Spatial Mapping of Myeloma Bone Marrow Microenvironment Using a Deep Learning Approach

Catherine SY Lecat, Yeman Brhane Hagos, Dominic Patel, Anna Mikolajczak, Thien-An Tran, Lydia Sarah Hui Lee, Manuel Rodriguez-Justo, Yinyin Yuan, Kwee Yong
Journal: Blood
Blood (2023) 142 (Supplement 1): 903.
https://doi.org/10.1182/blood-2023-179810
Published: 2023
Journal Articles

Infection Risk and Use of Prophylaxis with Anti-BCMA Bispecific T Cell Engagers and Belantamab Mafodotin for Patients with Relapsed and Refractory Multiple Myeloma

Rakesh Popat, Kathleen Cheok, Amrutha Sridhar, Conor Feely, Catriona Mactier, Annabel Mcmillan, Ashutosh D. Wechalekar, Neil Rabin, Jonathan Sive, Charalampia Kyriakou, Ke Xu, Xenofon Papanikolaou, Shameem Mahmood, Kwee Yong, Lydia Sarah Hui Lee
Journal: Blood
Blood (2023) 142 (Supplement 1): 4702.
https://doi.org/10.1182/blood-2023-182725
Published: 2023
Journal Articles

BCMA CARs in multiple myeloma: room for more?

Clinical Trials & Observations
Lydia Sarah Hui Lee, Kwee L. Yong
Journal: Blood
Blood (2021) 137 (21): 2859–2860.
https://doi.org/10.1182/blood.2021010833
Published: 2021
Journal Articles

An APRIL Based Chimeric Antigen Receptor to Simultaneously Target BCMA and TACI in Multiple Myeloma (MM) Has Potent Activity in Vitro and in Vivo

Lydia Sarah Hui Lee, MBBS, MRCP, MRCPath, BSc, Benjamin Owen Draper, BSc, MSc, Neil Chaplin, BSc, MSc, Brian Philip, PhD, Melody Chin, BSc, MSc, Daria Galas-Filipowicz, BSc, MSc, Simon Thomas, PhD, Evangelia Kokalaki, BSc, MSc, James Francis, PhD, Kwee L Yong, Martin A Pule, MD PhD
Journal: Blood
Blood (2016) 128 (22): 379.
https://doi.org/10.1182/blood.V128.22.379.379
Published: 2016